Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -51.30%30.14K | -51.30%30.14K | -86.10%50.65K | 97.66%27.23K | 194.00%41.57K | -7.58%61.88K | -7.58%61.88K | --364.43K | -12.48%13.78K | 430.58%14.14K |
| -Cash and cash equivalents | -51.30%30.14K | -51.30%30.14K | -86.10%50.65K | 97.66%27.23K | 194.00%41.57K | -7.58%61.88K | -7.58%61.88K | --364.43K | -12.48%13.78K | 430.58%14.14K |
| Receivables | -14.78%12.05K | -14.78%12.05K | ---- | -12.50%6.34K | 8.93%14.14K | 31.49%14.14K | 31.49%14.14K | --12.22K | 36.02%7.25K | 24.08%12.98K |
| -Accounts receivable | -14.78%12.05K | -14.78%12.05K | ---- | -12.50%6.34K | 8.93%14.14K | 31.49%14.14K | 31.49%14.14K | 885.32%12.22K | 36.02%7.25K | 24.08%12.98K |
| Total current assets | -44.51%42.19K | -44.51%42.19K | -86.55%50.65K | 59.69%33.57K | 105.42%55.71K | -2.18%76.02K | -2.18%76.02K | 685.25%376.64K | -0.22%21.02K | 106.61%27.12K |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --1 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -44.51%42.19K | -44.51%42.19K | -86.55%50.65K | 59.69%33.57K | 105.42%55.71K | -2.18%76.02K | -2.18%76.02K | 685.25%376.64K | -0.22%21.02K | 106.61%27.12K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -1.58%46.19K | -1.58%46.19K | ---- | ---- | ---- | 41,426.55%46.93K | 41,426.55%46.93K | ---- | ---- | ---- |
| -accounts payable | -47.05%21K | -47.05%21K | ---- | ---- | ---- | 35,000.88%39.66K | 35,000.88%39.66K | ---- | ---- | ---- |
| -Due to related parties current | 246.80%25.18K | 246.80%25.18K | ---- | ---- | ---- | --7.26K | --7.26K | ---- | ---- | ---- |
| Current liabilities | -1.58%46.19K | -1.58%46.19K | --2.66K | --5.89K | 5,017.39%5.89K | 41,426.55%46.93K | 41,426.55%46.93K | --0 | --0 | -99.46%115 |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | ---5.32K | --0 | -411,300.00%-4.11K | --0 | --0 | --0 | --0 | ---1 |
| Total liabilities | -1.58%46.19K | -1.58%46.19K | ---2.66K | --5.89K | 1,453.51%1.77K | 41,426.55%46.93K | 41,426.55%46.93K | --0 | --0 | -99.47%114 |
| Shareholders'equity | ||||||||||
| Share capital | 3.22%4.14M | 3.22%4.14M | 3.01%4.14M | 7.57%4.07M | 2.83%4.07M | 6.68%4.01M | 6.68%4.01M | --4.02M | 5.66%3.79M | 12.57%3.96M |
| -common stock | 3.22%4.14M | 3.22%4.14M | 3.01%4.14M | 7.57%4.07M | 2.83%4.07M | 6.68%4.01M | 6.68%4.01M | --4.02M | 5.66%3.79M | 12.57%3.96M |
| Retained earnings | 1.24%-4.21M | 1.24%-4.21M | -6.25%-4.17M | -9.04%-4.32M | -9.06%-4.29M | -9.84%-4.27M | -9.84%-4.27M | -9.12%-3.93M | -9.06%-3.96M | -8.99%-3.93M |
| Other equity interest | -75.14%71.15K | -75.14%71.15K | -69.55%87.15K | 40.16%271.53K | --271.53K | 40.52%286.18K | 40.52%286.18K | --286.18K | 185.52%193.72K | ---- |
| Total stockholders'equity | -113.74%-4K | -113.74%-4K | -85.85%53.31K | 31.70%27.69K | 99.73%53.94K | -62.50%29.1K | -62.50%29.1K | 110.47%376.64K | -0.22%21.02K | 429.30%27.01K |
| Total equity | -113.74%-4K | -113.74%-4K | -85.85%53.31K | 31.70%27.69K | 99.73%53.94K | -62.50%29.1K | -62.50%29.1K | 8.50%376.64K | -0.22%21.02K | 429.30%27.01K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.